In fiscal year 2022, Medicaid spent 8,813 U.S. dollars per full-year equivalent enrollee. However, spending per enrollee varied by state with North Dakota spending the most per enrollee at 13,001 U.S. dollars, while in South Carolina each Medicaid enrollee cost 5,199 U.S. dollars. This statistic illustrates Medicaid benefit spending per full-year equivalent (FYE) enrollee in the United States in FY 2022, by state.

2023 saw the largest expenditures on Medicaid in U.S. history. At that time about 894 billion U.S. dollars were expended on the Medicaid public health insurance program that aims to provide affordable health care options to low income residents and people with disabilities. Medicaid was signed into law in 1965. By 1975 around 13 billion U.S. dollars were spent on the program. Groups covered by Medicaid There are several components of the Medicaid health insurance program. The Children’s Health Insurance Program (CHIP) was started in 1997 to provide health coverage to families and children that could not afford care. As of 2021, children represented the largest distribution of Medicaid enrollees. Despite having the largest proportion of enrollees, those that were enrolled in Medicaid as children had the lowest spending per enrollee. As of 2021, disabled Medicaid enrollees had the highest spending per enrollee. Medicaid expenditures Currently, Medicaid accounts for 19 percent of all health care expenditure in the United States. Expenditures on Medicaid programs vary among the U.S. states and depend heavily on whether Medicaid expansion was accepted after the Affordable Care Act was enacted. California and New York are the top states with the highest Medicaid expenditures. It is projected that Medicaid expenditure will continue to increase at both the state and federal levels.

The United States has the highest expenditure on health care per capita globally. However, the U.S. has an unique way of paying for their health care where a majority of the expenditure falls upon private insurances. In FY 2024, around one ***** of all health expenditure is paid by private insurance. Public insurance programs Medicare and Medicaid accounted for ** and ** percent, respectively, of health expenditure during that same year. U.S. health care system Globally health spending has been increasing among most countries. However, the U.S. has the highest public and private per capita health expenditure among all countries globally, followed by Switzerland. As of 2020, annual health care costs per capita in the United States totaled to over ** thousand U.S. dollars, a significant amount considering the average U.S. personal income is around ** thousand dollars. Out of pocket costs in the U.S. Aside from overall high health care costs for U.S. residents, the total out-of-pocket costs for health care have been on the rise. In recent years, the average per capita out-of-pocket health care payments have exceeded *** thousand dollars. Physician services, dental services and prescription drugs account for the largest proportion of out-of-pocket expenditures for U.S. residents.

More than one in four hospitalizations for those with both Medicare and full Medicaid coverage was potentially avoidable, according to findings reported in Medicare-Medicaid Eligible Beneficiaries and Potentially Avoidable Hospitalizations, published in Volume 4, Issue 1 of the Medicare and Medicaid Research Review. Using data from 2007 to 2009, the study examined potentially avoidable hospitalizations rates by setting, state, and medical condition, and the average cost of these events. Beneficiaries in institutions were much more likely to have these events - 16 percent of beneficiaries in the study population were in an institution, yet comprised 45 percent of all potentially avoidable hospitalizations. The range in rates per 1,000 person years across the states was considerable from a low of 59 (Utah) to a high of 197 (Mississippi), a more than a threefold difference. Five conditions were responsible for nearly 80 percent of potentially avoidable hospitalizations. From 2007 to 2009, the national and state rates were fairly consistent.

The Medicare Part D by Drug dataset presents information on spending for drugs prescribed to Medicare beneficiaries enrolled in Part D by physicians and other healthcare providers. Drugs prescribed in the Medicare Part D program are drugs patients generally administer themselves.The dataset focuses on average spending per dosage unit and change in average spending per dosage unit over time. It also includes spending information for manufacturer(s) of the drugs as well as consumer-friendly information of drug uses and clinical indications.Drug spending metrics for Part D drugs are based on the gross drug cost, which represents total spending for the prescription claim, including Medicare, plan, and beneficiary payments. The Part D spending metrics do not reflect any manufacturers’ rebates or other price concessions as CMS is prohibited from publicly disclosing such information.

In 2021, Medicare spending per beneficiary amounted an average of ****** U.S. dollars, a fairly sharp increase from the previous year. Medicare spending per person has being steadily rising over the provided time interval. Growth in health care spending is influenced by increasing volume and use of services, new technologies, and rising prices. This statistic displays the per capita Medicare spending in the U.S. from 2010 to 2021.

The Shared Savings Program County-level Aggregate Expenditure and Risk Score Data on Assignable Beneficiaries Public Use File (PUF) for the Medicare Shared Savings Program (Shared Savings Program) provides aggregate data consisting of per capita Parts A and B FFS expenditures, average CMS-HCC prospective risk scores and total person-years for Shared Savings Program assignable beneficiaries by Medicare enrollment type (End Stage Renal Disease (ESRD), disabled, aged/dual eligible, aged/non-dual eligible).

The article, Trends In Complicated Newborn Hospital Stays and Costs, 2002-2009, Implications For the Future, published in Volume 4, Issue 4 of Medicare and Medicaid Research Review, assessed all-payer administrative data from the Healthcare Cost and Utilization Project HCUP Nationwide Inpatient Sample NIS, to examine trends 2002-2009 in complicated newborn hospital stays. Findings indicate that complicated births and hospital discharges within 30 days of birth remained relatively constant, but average costs per discharge increased substantially. Most strikingly, over time, the proportion of complicated births billed to Medicaid increased, while the proportion paid for by private payers decreased. Complications for infants with Medicaid were more likely due to preterm birth-low birth weight and respiratory distress, while complications for those with private insurance were more likely due to jaundice. Policies to prevent common birth complications have the potential to reduce costs for public programs and improve birth outcomes.

BackgroundThis study (NCT01682005) aims to assess clinical and cost impacts of complete and incomplete rotavirus (RV) vaccination.MethodsBeneficiaries who continuously received medical and pharmacy benefits since birth were identified separately in Truven Commercial Claims and Encounters (2000–2011) and Truven Medicaid Claims (2002–2010) and observed until the first of end of insurance eligibility or five years. Infants with ≥1 RV vaccine within the vaccination window (6 weeks-8 months) were divided into completely and incompletely vaccinated cohorts. Historically unvaccinated (before 2007) and contemporarily unvaccinated (2007 and after) cohorts included children without RV vaccine. Claims with International Classification of Disease 9th edition (ICD-9) codes for diarrhea and RV were identified. First RV episode incidence, RV-related and diarrhea-related healthcare resource utilization after 8 months old were calculated and compared across groups. Poisson regressions were used to generate incidence rates with 95% confidence intervals (CIs). Mean total, inpatient, outpatient and emergency room costs for first RV and diarrhea episodes were calculated; bootstrapping was used to construct 95% CIs to evaluate cost differences.Results1,069,485 Commercial and 515,557 Medicaid patients met inclusion criteria. Among commercially insured, RV incidence per 10,000 person-years was 3.3 (95% CI 2.8–3.9) for completely, 4.0 (95% CI 3.3–5.0) for incompletely vaccinated, and 20.9 (95% CI 19.5–22.4) for contemporarily and 40.3 (95% CI 38.6–42.1) for historically unvaccinated. Rates in Medicaid were 7.5 (95% CI 4.8–11.8) for completely, 9.0 (95% CI 6.5–12.3) for incompletely vaccinated, and 14.6 (95% CI 12.8–16.7) for contemporarily and 52.0 (95% CI 50.2–53.8) for historically unvaccinated. Mean cost for first RV episode per cohort member was $15.33 (95% CI $12.99-$18.03) and $4.26 ($95% CI $2.34-$6.35) lower for completely vaccinated versus contemporarily unvaccinated in Commercial and Medicaid, respectively.ConclusionsRV vaccination results in significant reduction in RV infection. There is evidence of indirect benefit to unvaccinated individuals.

In 1970, some 7.5 billion U.S. dollars were spent on the Medicare program in the United States. Fifty plus years later, this figure stood at 1,122.1 billion U.S. dollars. This statistic depicts total Medicare spending from 1970 to 2024. Increasing Medicare coverage Medicare is the federal health insurance program in the U.S. for the elderly and those with disabilities. In the U.S., the share of the population with any type of health insurance has increased to over 90 percent in the past decade. As of 2019, approximately 18 percent of the U.S. population was covered by Medicare in particular. Increasing Medicare costs Medicare costs are forecasted to continue increasing over time, with outlays rising to a predicted 1.78 trillion U.S. dollars by 2031 as the population continues to age. Certain diseases of old age, such as Alzheimer’s disease, are increasing in prevalence in the U.S., which will reflect on healthcare costs for the elderly. In 2021, Alzheimer's disease was estimated to cost Medicare and Medicaid around 239 billion U.S. dollars in care costs; by 2050, this number is projected to climb to 798 billion dollars.

The Quarterly Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information files contain formulary, pharmacy network, and pricing data for Medicare Prescription Drug Plans and Medicare Advantage (MA) Prescription Drug Plans (with the exception of employer and Program of All-Inclusive Care for the Elderly plans).

Notice: CMS has identified an issue that resulted in a 15% coinsurance for plans with Defined Standard benefits to be listed rather than a 25% coinsurance in the Beneficiary Cost File under certain scenarios. This issue affected the 2023 Q4 to 2024 Q3 data. CMS will re-post the corrected data in batches between now and May 2025.

These non-identifiable files are available on a quarterly basis and are comprised of the following tables:

Plan Information - Information such as plan name, contract ID, plan ID, service area, and plan type.
Geographic Locator - MA and Prescription Drug Plans region codes and county codes.
Basic Drugs Formulary - Formulary details for each plan including National Drug Codes (NDCs), cost share tier level, and indicators for step therapy, quantity limits, and prior authorization.
Excluded Drugs Formulary - Enhanced alternative plans may elect to provide a supplemental benefit and cover excluded drugs. File includes formulary details for excluded drugs that are covered by the plan (for enhanced alternative plans only).
Beneficiary Cost - Plan level cost sharing details for preferred, non-preferred, and mail order network pharmacies.
Pharmacy Network - National Provider Identifier (NPI) numbers for each network pharmacy including preferred, retail, and mail order indicators.
Pricing - Plan level average monthly costs for formulary Part D drugs (note: this table is only available in the quarterly files).
Indication Based Coverage Formulary File - Includes drugs covered based on FDA-approved indication for each plan.
Insulin Beneficiary Cost File - Plan level cost sharing details for insulin at preferred, non-preferred and mail order network pharmacies.

These are large files and can take time to download.

Please read the “Agreement for Use” in the Resources section below. This document contains important information regarding timeframes for obtaining data as well as data accuracy and integrity.

The Monthly Prescription Drug Plan Formulary and Pharmacy Network Information is also available to access for the monthly level information.

Please note: The Part D benefit year information for plans become available in October of the year prior. For example, year 2024 data is available in the fourth quarter file of 2023. Year 2024 data continues to be available in the Q1-Q3 2024 files, then in the fourth quarter of 2024 year 2025 data becomes available.

Estimated release dates for upcoming 2025 quarterly data (files reflect data for the quarter that ended the month before the file was released):

4/23/25
7/30/25

Files older than contract year 2019 can be purchased.

Note: This dataset has been limited to show metrics for Ramsey County, Minnesota.

This dataset represents COVID-19 hospitalization data and metrics aggregated to county or county-equivalent, for all counties or county-equivalents (including territories) in the United States. COVID-19 hospitalization data are reported to CDC’s National Healthcare Safety Network, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN and included in this dataset represent aggregated counts and include metrics capturing information specific to COVID-19 hospital admissions, and inpatient and ICU bed capacity occupancy.

Reporting information: As of December 15, 2022, COVID-19 hospital data are required to be reported to NHSN, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN represent aggregated counts and include metrics capturing information specific to hospital capacity, occupancy, hospitalizations, and admissions. Prior to December 15, 2022, hospitals reported data directly to the U.S. Department of Health and Human Services (HHS) or via a state submission for collection in the HHS Unified Hospital Data Surveillance System (UHDSS). While CDC reviews these data for errors and corrects those found, some reporting errors might still exist within the data. To minimize errors and inconsistencies in data reported, CDC removes outliers before calculating the metrics. CDC and partners work with reporters to correct these errors and update the data in subsequent weeks. Many hospital subtypes, including acute care and critical access hospitals, as well as Veterans Administration, Defense Health Agency, and Indian Health Service hospitals, are included in the metric calculations provided in this report. Psychiatric, rehabilitation, and religious non-medical hospital types are excluded from calculations. Data are aggregated and displayed for hospitals with the same Centers for Medicare and Medicaid Services (CMS) Certification Number (CCN), which are assigned by CMS to counties based on the CMS Provider of Services files. Full details on COVID-19 hospital data reporting guidance can be found here: https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf

Calculation of county-level hospital metrics: County-level hospital data are derived using calculations performed at the Health Service Area (HSA) level. An HSA is defined by CDC’s National Center for Health Statistics as a geographic area containing at least one county which is self-contained with respect to the population’s provision of routine hospital care. Every county in the United States is assigned to an HSA, and each HSA must contain at least one hospital. Therefore, use of HSAs in the calculation of local hospital metrics allows for more accurate characterization of the relationship between health care utilization and health status at the local level. Data presented at the county-level represent admissions, hospital inpatient and ICU bed capacity and occupancy among hospitals within the selected HSA. Therefore, admissions, capacity, and occupancy are not limited to residents of the selected HSA. For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA. For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.

Metric details: Time period: data for the previous MMWR week (Sunday-Saturday) will update weekly on Thursdays as soon as they are reviewed and verified, usually before 8 pm ET. Updates will occur the following day when reporting coincides with a federal holiday. Note: Weekly updates might be delayed due to delays in reporting. All data are provisional. Because these provisional counts are subject to change, including updates to data reported previously, adjustments can occur. Data may be updated since original publication due to delays in reporting (to account for data received after a given Thursday publication) or data quality corrections. New hospital admissions (count): Total number of admissions of patients with laboratory-confirmed COVID-19 in the previous week (including both adult and pediatric admissions) in the entire jurisdiction New Hospital Admissions Rate Value (Admissions per 100k): Total number of new admissions of patients with laboratory-confirmed COVID-19 in the past week (including both adult and pediatric admissions) for the entire jurisdiction divided by 2019 intercensal population estimate for that jurisdiction multiplied by 100,000. (Note: This metric is used to determine each county’s COVID-19 Hospital Admissions Level for a given week). New COVID-19 Hospital Admissions Rate Level: qualitative value of new COVID-19 hospital admissions rate level [Low, Medium, High, Insufficient Data] New hospital admissions percent change from prior week: Percent change in the current weekly total new admissions of patients with laboratory-confirmed COVID-19 per 100,000 population compared with the prior week. New hospital admissions percent change from prior week level: Qualitative value of percent change in hospital admissions rate from prior week [Substantial decrease, Moderate decrease, Stable, Moderate increase, Substantial increase, Insufficient data] COVID-19 Inpatient Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 (including both adult and pediatric patients) within the in the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (patients hospitalized with confirmed COVID-19) and denominators (staffed inpatient beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction. COVID-19 Inpatient Bed Occupancy Level: Qualitative value of inpatient beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data] COVID-19 Inpatient Bed Occupancy percent change from prior week: The absolute change in the percent of staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed inpatient beds in the past week, compared with the prior week, in the entire jurisdiction. COVID-19 ICU Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by adult patients with confirmed COVID-19 within the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (adult patients hospitalized with confirmed COVID-19) and denominators (staffed adult ICU beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction. COVID-19 ICU Bed Occupancy Level: Qualitative value of ICU beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data] COVID-19 ICU Bed Occupancy percent change from prior week: The absolute change in the percent of staffed ICU beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed adult ICU beds for the past week, compared with the prior week, in the in the entire jurisdiction. For all metrics, if there are no data in the specified locality for a given week, the metric value is displayed as “insufficient data”.

NAPSG Foundation simply changed the symbology based on bed utilization and filter set to Hospital Type is not 'Psychiatric Hospital'. NAPSG Foundation is not the host of this dataset, see notes below for more details.Also - it is not clear how often the bed utilization rate updates, but it is now presumed to be 4x per year. THIS IS NOT A REAL-TIME DATASET.Definitive Healthcare is the leading provider of data, intelligence, and analytics on healthcare organizations and practitioners. In this service, Definitive Healthcare provides intelligence on the numbers of licensed beds, staffed beds, ICU beds, and the bed utilization rate for the hospitals in the United States. Please see the following for more details about each metric, data was last updated on 17 March 2020:Number of Licensed beds: is the maximum number of beds for which a hospital holds a license to operate; however, many hospitals do not operate all the beds for which they are licensed. This number is obtained through DHC Primary Research. Licensed beds for Health Systems are equal to the total number of licensed beds of individual Hospitals within a given Health System. Number of Staffed Bed: is defined as an "adult bed, pediatric bed, birthing room, or newborn ICU bed (excluding newborn bassinets) maintained in a patient care area for lodging patients in acute, long term, or domiciliary areas of the hospital." Beds in labor room, birthing room, post-anesthesia, postoperative recovery rooms, outpatient areas, emergency rooms, ancillary departments, nurses and other staff residences, and other such areas which are regularly maintained and utilized for only a portion of the stay of patients (primarily for special procedures or not for inpatient lodging) are not termed a bed for these purposes. Definitive Healthcare sources Staffed Bed data from the Medicare Cost Report or Proprietary Research as needed. As with all Medicare Cost Report metrics, this number is self-reported by providers. Staffed beds for Health Systems are equal to the total number of staffed beds of individual Hospitals within a given Health System. Total number of staffed beds in the US should exclude Hospital Systems to avoid double counting. ICU beds are likely to follow the same logic as a subset of Staffed beds. Number of ICU Beds - ICU (Intensive Care Unit) Beds: are qualified based on definitions by CMS, Section 2202.7, 22-8.2. These beds include ICU beds, burn ICU beds, surgical ICU beds, premature ICU beds, neonatal ICU beds, pediatric ICU beds, psychiatric ICU beds, trauma ICU beds, and Detox ICU beds. Bed Utilization Rate: is calculated based on metrics from the Medicare Cost Report: Bed Utilization Rate = Total Patient Days (excluding nursery days)/Bed Days AvailablePotential Increase in Bed Capacity: This metric is computed by subtracting “Number of Staffed Beds from Number of Licensed beds” (Licensed Beds – Staffed Beds). This would provide insights into scenario planning for when staff can be shifted around to increase available bed capacity as needed. Hospital Definition: Definitive Healthcare defines a hospital as a healthcare institution providing inpatient, therapeutic, or rehabilitation services under the supervision of physicians. In order for a facility to be considered a hospital it must provide inpatient care. Hospital types are defined by the last four digits of the hospital’s Medicare Provider Number. If the hospital does not have a Medicare Provider Number, Definitive Healthcare determines the Hospital type by proprietary research. Hospital Types:· Short Term Acute Care Hospital (STAC)o Provides inpatient care and other services for surgery, acute medical conditions, or injurieso Patients care can be provided overnight, and average length of stay is less than 25 days· Critical Access Hospital (CAH)o 25 or fewer acute care inpatient bedso Located more than 35 miles from another hospitalo Annual average length of stay is 96 hours or less for acute care patientso Must provide 24/7 emergency care serviceso Designation by CMS to reduce financial vulnerability of rural hospitals and improve access to healthcare· Religious Non-Medical Health Care Institutionso Provide nonmedical health care items and services to people who need hospital or skilled nursing facility care, but for whom that care would be inconsistent with their religious beliefs· Long Term Acute Care Hospitalso Average length of stay is more than 25 dayso Patients are receiving acute care - services often include respiratory therapy, head trauma treatment, and pain management· Rehabilitation Hospitalso Specializes in improving or restoring patients' functional abilities through therapies· Children’s Hospitalso Majority of inpatients under 18 years old· Psychiatric Hospitalso Provides inpatient services for diagnosis and treatment of mental illness 24/7o Under the supervision of a physician· Veteran's Affairs (VA) Hospital o Responsible for the care of war veterans and other retired military personnelo Administered by the U.S. VA, and funded by the federal government· Department of Defense (DoD) Hospitalo Provides care for military service people (Army, Navy, Air Force, Marines, and Coast Guard), their dependents, and retirees (not all military service retirees are eligible for VA services) For more information please visit - https://www.definitivehc.com/ - or contact sales@definitivehc.com

In 2021, Medicare spent an average of more than 13,139 U.S. dollars per enrollee in New York, while the average for the United States was 11,080 U.S. dollars per enrollee. This statistic depicts the leading ten U.S. states based on Medicare spending per enrollee in 2021.

This statistic illustrates the health spending distribution of state and local government in the United States from 2013 to 2022. In 2022, 36 percent of state and local government health spending in the U.S. was spent on Medicaid. Health spending distributionHealth spending by the state and local government in the United States is divided among four major categories. As of 2021, 36 percent of spending was dedicated to Medicaid, 33 percent to private insurance premiums, 29 percent to other health programs, and three percent to Medicare payroll tax for state and local workers. In 1960, the majority of spending on prescription medications came from the consumer’s pocket, today out-of-pocket spending for prescriptions has decreased to about 13 percent. Among OECD countries, the United States spends the largest portion of its gross domestic product on health care expenditures, totaling nearly 17 percent in 2022. In comparison, the United Kingdom spent about 11.3 percent of the nation’s GDP on health care. High income countries spend over 6,100 U.S. dollars per capita compared to the world average of around 1,177 U.S. dollars per person. Health care spending in the United States has steadily risen over the last decades. In 1970, 355 U.S. dollars was expended on health care per capita in the United States; by 2021, this figure had risen to 12,591 U.S. dollars per capita. The increase in health care expenditure in the country may lie in parallel with the increase in premiums. Spending for hospitals, physicians, specialists, and dentists are significantly higher than other high income countries. Health care provider prices are especially high in the U.S. due to greater access to medical technologies as well as the obesity epidemic in the country.

The overall average annual payments for health services made by Medicare beneficiaries over the age of 65 with Alzheimer's or other dementias was 44,814 U.S. dollars, compared to 15,053 U.S. dollars for beneficiaries without Alzheimer's.

Healthcare premiums under the Affordable Care Act (ACA) have fallen for all consumers nationally in 2023 when compared with the previous two years. This is due to a system of tax credits provided by the American Rescue Plan and the Inflation Reduction Act passed by the United States Congress. After these tax credits, the average person with ACA coverage pays an average monthly premium of *** U.S. dollars, down from *** U.S. dollars in 2021. A report from the U.S. Centers for Medicare & Medicaid Services estimates that due to the tax credits, consumers nationally on average save over *** U.S. dollars per year in premiums. The ACA created a federally run healthcare exchange which is used by ** states as of 2023. States can also decide to run their own exchange - due to politics or practicality - of which there are ** plus the District of Columbia.

The Centers for Medicare and Medicaid Services estimate that prescription drug expenditure in the United States will reach around 460 billion U.S. dollars in 2024. This amount includes only retail drug spending, excluding nonretail. Estimations of drug spending can vary by investigating organization. For the U.S., among the most relevant drug spending calculations are provided by CMS, ASPE (Assistant Secretary for Planning and Evaluation), and pharmaceutical market researcher IQVIA. High drug prices in the U.S.The United States is the country with the highest total drug spending, and also with the highest per capita pharmaceuticals spending among developed countries. This is mostly connected to higher drug prices in the United States. For example, the price for the blockbuster drug Humira was almost three times higher in the United States than in Germany in 2017. But whereas in other countries, governments more or less directly control drug prices, the U.S. leaves drug pricing to market competition. As a consequence, the U.S. market is the most profitable for pharmaceutical companies. Where the money is spentNearly half of all Americans have taken at least one prescription medicine within the preceding month. The therapeutic areas where spending is the highest are ‘traditionally’ to be found among antidiabetics, oncologics, autoimmune, and respiratory diseases. Based on number of prescriptions filled, antihypertensives, pain reliever, and mental health drugs are the leading classes.

In 2024, 27 million people in the United States had no health insurance. The share of Americans without health insurance saw a steady increase from 2015 to 2019 before starting to decline from 2020 to 2024. Factors like the implementation of Medicaid expansion in additional states and growth in private health insurance coverage led to the decline in the uninsured population, despite the economic challenges due to the pandemic in 2020. Positive impact of Affordable Care Act In the U.S. there are public and private forms of health insurance, as well as social welfare programs such as Medicaid and programs just for veterans such as CHAMPVA. The Affordable Care Act (ACA) was enacted in 2010, which dramatically reduced the share of uninsured Americans, though there’s still room for improvement. In spite of its success in providing more Americans with health insurance, ACA has had an almost equal number of proponents and opponents since its introduction, though the share of Americans in favor of it has risen since mid-2017 to the majority. Persistent disparity among ethnic groups The share of uninsured people is higher in certain demographic groups. For instance, Hispanics continue to be the ethnic group with the highest rate of uninsured people, even after ACA. Meanwhile the share of uninsured White and Asian people is lower than the national average.

In 2021, about ***** percent of all Medicare enrolled beneficiaries in the United States were aged 85 years or older. Medicare provides low-cost health coverage to people over the age of ** and those with disabilities and certain medical conditions. This statistic depicts the distribution of Medicare enrollees in 2021, by age group.